Study of relations between matrix metalloproteinase-9 polymorphism (C-1562T) and acute coronary syndrome in Han population of China

Chinese Journal of Medical Genetics

Volumn 22, Issue 3, 2005, Pages 313-316

  Tang, Li Jiang ^a   Chen, Xiao Feng ^a   Zhu, Min ^a   Shen, Wei Feng ^b   Jiang, Jian Jun ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Genetic polymorphism; Matrix metalloproteinases

Indexed keywords

DNA; GELATINASE B;

ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CHINA; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; GENETIC POLYMORPHISM; GENOTYPE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ACUTE CORONARY SYNDROME; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 20644459018     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med, 1992, 326:242-250.
2. Zaltsman AB, Newby AC. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity. Atherosclerosis, 1997, 130:61-70.
3. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest, 1994, 94:2493-2503.
4. Zhang B, Shu Ye, Stefan-Martin H, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation, 1999, 99:1788-1794.
5. Morgan AR, Zhang B, Tapper W, et al. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. Haplotypic J Mol Med, 2003, 81:321-326.
6. Wang J, Warzecha D, Wilcken D, et al. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin Sci (Lond), 2001, 101:87-92.
7. Cho HJ, Chae IH, Park KW, et al. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J Hun Genet, 2002, 47:88-91.
8. Zhao YH, Wang YN, Zhu JQ, et al. Association of the polymorphism of platelet membrane glycoprotien I a gene with myocardial infarction. Chin J Med Genet, 2003, 20:417-20.
9. Burzotta F, Leone AM, Paciaroni K, et al. G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome. Haematologica, 2004, 89:1134-1138.
10. Kullo U, Elwards ED, Schwartz RS. Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med, 1998, 129:1050-1060.
11. Davies MJ, Richardson PO, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J, 1993, 69:377-381 .
12. Brown DL, Hibbs MS, Kearney M, et al. Identification of 92-KD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation, 1995, 91:2125-2131.
13. Inokubo Y, Hanada H, Ishizaka H, et al. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J, 2001, 141:211-217.
14. Shah PK. Pathophysiology of plaque rupture and the concept of plaque stabilization. Cardiol Clin, 2003, 21:303-314.
15. Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation, 2003, 107:1579-1585.